checkAd

SpineGuard Strengthens Its US Organization

Nachrichtenquelle: Business Wire (engl.)
15.04.2021, 18:00  |  1201   |   |   

Regulatory News:

SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants announced today the appointment of Patrick Pilcher as Vice President of Sales & Marketing for the United States, effective May 3, 2021.

Patrick Pilcher joins SpineGuard as Vice President of Sales and Marketing with the U.S. responsibility for driving distribution channel development, launching the new DSG Connect platform and contributing to industry partnership activities to further leverage DSG, SpineGuard’s core technology.

Mr. Pilcher has over 30 years of sales, sales management, marketing and business development experience in the medical device and peripheral spine surgery arena. Over the course of his career, his areas of expertise were tied to spinal fusion, dynamic stabilization, motion preservation, neuromonitoring, and orthobiologic modalities. During that time, he held roles in both legacy corporations such as Medtronic (SDG), Zimmer and start-ups with Spinal Concepts (Abbott), Pioneer Surgical (Surgalign), Surgical Monitoring (Sentient Medical), Spinal Elements, AlloSource and CellRight Technologies.

Pierre Jérôme, co-founder, Chairman and CEO of SpineGuard, said: “With U.S. profitable operations, the FDA clearance of our DSG Connect platform and a secured cash runway, the right conditions are now in place for strengthening our US organization. I am thrilled to welcome Patrick aboard! His passion for meaningful medtech innovation and extensive US spine industry experience in shaping and driving the execution of growth strategies make him the suitable leader we need to move our U.S. business forward and expand the adoption of our DSG technology.”

Patrick Pilcher added:I am excited at the opportunity to join this seasoned team and drive SpineGuard in the U.S. to further integrate its elegant, and technologically advanced DSG solutions into the mainstream of the evolving paradigm of spinal instrumentation. Our mantra remains in promoting the safest means of bony fixation with a significant reduction of radiation and time, while mitigating the inherent risks of neuro-vascular insults. We are poised to bring safety and confidence to any hospital or surgery center where spine cases using pedicle fixation are performed addressing a range of cases from primary to complex deformities.”

Seite 1 von 2
Spineguard Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

SpineGuard Strengthens Its US Organization Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants announced today the appointment of Patrick Pilcher …

Nachrichten des Autors

Titel
Titel
Titel
Titel